Andrey Botikov, who worked as a senior researcher at the Gamaleya National Research Center for Ecology and Mathematics, was found dead in his apartment on Thursday, Russian News Agency TASS quoted the Investigative Committee of the Russian Federation as saying.
Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot. The two doses of Sputnik V are administered at a gap of 21-30 days.
Sputnik Light Covid vaccine is the 9th vaccine to be approved for emergency use in India.
The interim data of the efficacy trial from Russia has shown an efficacy of 65.4 per cent against COVID-19, 21 days after immunisation.
The study was conducted at the leading Italian research institute for infectious diseases, by a joint Italian-Russian team of researchers representing the Institute and the Gamaleya Center in the equal laboratory conditions on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus neutralising activity (VNA) against Wuhan variant, said a report.
The Gamaleya Institute believes that both Sputnik V and Sputnik Light will neutralise the latest Omicron variant, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) said in a statement.
Russia's Health Ministry will register the Sputnik vaccine for children aged 12-17 on Wednesday, with shots expected to be available at the end of December.
Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India's anti-COVID inoculation programme after getting emergency use authorisation from India's Drug Regulator in April.
The World Health Organisation is still reviewing data about Russia's Sputnik V vaccine as part of hopes that it can be approved by the UN health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent.
CDSCO in July had refused to grant emergency-use authorisation to Sputnik-Light, ruling out the need for the conduct of the phase III trial of the Russian vaccine in the country.
According to an SBI report, 43 per cent of the eligible population in India stands vaccinated against Covid-19 with the first dose and 12 per cent with the second dose.
Panacea Biotec has partnered Russian Direct Investment Fund (RDIF) to launch the Russian Sputnik V vaccine in India.
Mentioning the doubling of the capacity of Sputnik V in September, the release stated, "Sputnik V has built production partnership with producers in 14 countries and will additionally double its capacity in September.
Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft-launched the vaccine in India in May 2021 after receiving Emergency Use Authorization (EUA) in April 2021.
The RDIF and Serum Institute of India, the world’s largest vaccine producer, will start production of Sputnik V vaccine in September.
Dr Reddys Laboratories Ltd, which soft-launched Russia's COVID-19 vaccine, Sputnik V on May 14 has expanded the pilot project to over 50 other cities and towns in the country.
Russia became the first country in the world to register a vaccine against the coronavirus, dubbed Sputnik V, in August 2020.
Deputy Mayor Anastasia Rakova said 100 volunteers have been recruited who haven't been previously infected with the coronavirus and don't have health issues that would prevent them from getting the shots.
Indraprastha Apollo in Delhi started administering Sputnik V in a staged manner from Wednesday. Around 1,000 people have been vaccinated so far, a hospital spokesperson said.
Tejashwi Yadav and Tej Pratap Yadav, both the sons of Lalu Prasad Yadav, took their Sputnik shots at the Medanta hospital in Patna.
Top News
Latest News
